Recruiting Influenza Studies in St Louis
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma....
Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
The study regimen will be administered on an outpatient basis and all medications are administered intravenously (IV). Subjects will receive treatment on Day 1 and Day 15 of each 28-day cycle consisti...
About Influenza Clinical Trials in St Louis
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. It causes millions of illnesses and thousands of deaths annually. Prevention through vaccination is the primary strategy, with antiviral medications available for treatment.
There are currently 2 influenza clinical trials recruiting participants in St Louis, MISSOURI. These studies are seeking a combined 154 participants. Research is being sponsored by Giselle Sholler, Tiago Biachi de Castria. Clinical trial participation is free and participants receive study-related medical care at no cost.
Influenza Clinical Trials in St Louis — FAQ
Are there influenza clinical trials in St Louis?
Yes, there are 2 influenza clinical trials currently recruiting in St Louis, MISSOURI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in St Louis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St Louis research site will contact you about next steps.
Are clinical trials in St Louis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St Louis studies also compensate for your time and travel.
What influenza treatments are being tested?
The 2 active trials in St Louis are testing new therapies including novel drugs, biologics, and treatment approaches for influenza.
Data updated March 2, 2026 from ClinicalTrials.gov